Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6351–6400 of 75459
Effective April 17, 2025, Reed Hastings will transition to serve as Chairman of the board of directors of the Company (the “Board”) and non-executive director.
Current director Jennifer Banner will not stand for re-election at, and her current term as a director will end, at the Annual Meeting.
On April 16, 2025, the Board, on the recommendation of the Governance Committee of the Board, nominated Harold Zeitz for election to the Board as an independent director at the 2025 annual meeting of stockholders.
On April 14, 2025, Gary P. Fayard, currently a director on the Board of Directors (the “Board”) of Monster Beverage Corporation (the “Company”), provided notice to the Board and management of the Company of his intention not to stand for reelection at the 2025 Annual Meeting of the Stockholders (the “2025 Annual Meeting”).
On April 16, 2025, J. Drayton Wise notified Insmed Incorporated (the “Company”) of his decision to resign from his position as the Company’s Chief Commercial Officer for personal and medical reasons, effective immediately.
Effective April 15, 2025, the board of directors of the Company appointed Gerald Cummins to replace Mr. Galea as the Company’s Chief Compliance Officer.
Effective April 15, 2025, Frank Galea resigned as Chief Compliance Officer of PennantPark Floating Rate Capital Ltd. (the “Company”).
Effective April 15, 2025, Frank Galea resigned as Chief Compliance Officer of PennantPark Investment Corporation (the “Company”).
Effective April 15, 2025, the board of directors of the Company appointed Gerald Cummins to replace Mr. Galea as the Company’s Chief Compliance Officer.
On April 16, 2025, the Board appointed Howard H. Berman, Ph.D. as a Class III director of the Company, effective at the Effective Time.
In addition, on April 16, 2025, in connection with the Agreement, Franklin Berger informed the Board that he would retire following the end of his current term as a Class I director at the 2027 Annual Meeting.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
In addition, Kevin M. Barry was appointed as a director of the Company immediately following the Effective Time.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
On April 15, 2025, Charles Watts, M.D., a member of the Board of Directors (the “Board”) of Biodesix, Inc. (the “Company”), notified the Company of his intention to resign from his position as a director of the Board and as a member of the Compensation Committee, effective at the conclusion of the Company’s 2025 Annual Meeting of Stockholders on May 20, 2025.
Christopher R. Delaney, a named executive officer in the 2025 proxy statement, left his employment with The Goodyear Tire & Rubber Company (the “Company”) effective on April 14, 2025.
On April 15, 2025, the board of directors (the “Board”) of NewAmsterdam Pharma Company N.V. (the “Company”) appointed Adele Gulfo to serve as a member of the Board.
On April 12, 2025, Lynn Liang notified the Board of Directors (the “Board”) of Health In Tech, Inc., a Nevada corporation (the “Company”) that she is resigning from the Board effective April 18, 2025.
the Board elected William (Chip) Clark as a Class I director
On April 16, 2025, the Board of Directors (the "Board") of LGL Group appointed Vice Admiral Colin J. Kilrain, USN (Ret.), as a director of the Company, effective immediately, to serve until the Company's next annual meeting of stockholders or until his successor is duly elected and qualified.
On April 17, 2025, Waterstone Financial, Inc. (the “Company”), announced today that Michael Hansen has decided to retire as a Director of the Company and its wholly-owned subsidiary WaterStone Bank SSB.
On April 16, 2025 the Board of Directors (the “Board”) of Asana, Inc. (the “Company”) appointed Marc Boroditsky to serve on the Board as a Class I director, effective as of April 16, 2025.
On April 14, 2025, the majority shareholders of the Corporation elected James C. Ford to serve as a member of the Board of Directors of the Corporation, effective May 1, 2025.
On April 2, 2025, the majority shareholder of the THC Therapeutics, Inc. (the "Company"), voted to remove Brandon Romanek from the Board of Directors of the Company. Further, on that same day, the remaining Board of Directors removed Mr. Romanek from any and all positions held at the Company.
Mr. Corrales assumed a new role within Southern Peru Copper Corporation, Sucursal del Perú as the Advising Director of New Projects effective April 10, 2025.
On April 10, 2025, the Board of Directors of Southern Copper Corporation (“SCC” or the “Company”) appointed Mr. Juan Fernando Nuñez Chávez as the Company’s Vice President, Explorations to replace Mr. Edgard Corrales.
Alan Connolly, CRH’s Interim Chief Financial Officer, will continue in that role until May 11, 2025, following which Mr. Connolly will return to his previous role with CRH as Director of Strategic Finance.
On April 17, 2025, CRH public limited company (‘CRH’ or the ‘Company’) announced the appointment of Nancy Buese as Chief Financial Officer, effective as of May 12, 2025.
Todd L. Capitani, the Company’s current Chief Financial Officer, who previously announced his retirement, will continue with the Company until August 15, 2025 to support this leadership transition.
On April 17, 2025 , Shore Bancshares, Inc. (the “Company”) announced that it appointed Charles S. Cullum to Executive Vice President and Chief Financial Officer effective April 21, 2025.
On April 16, 2025, Sweetgreen, Inc. (the “Company”) and Rossann Williams, the Company’s Chief Operating Officer, mutually agreed that Ms. Williams would leave her employment with the Company, effective immediately.
Pursuant to the Letter Agreement, effective as of April 21, 2025, Dr. Taub will transition from her current role and responsibilities to a new role as a Senior Scientific and Medical Advisor to the Company through the end of 2025.
On May 16, 2025, the Company appointed Cyril Wallace, the Company’s Chief Executive Officer, to the Company’s board of directors.
The disclosures set forth in Item 1.01 regarding Norman E. Snyder’s retirement and resignation from the positions of Chief Executive Officer and director and the terms of the Transition Agreement are incorporated into this section (b) by this reference.
The disclosures set forth in Item 1.01 regarding Cyril Wallace’s appointment as Chief Executive Officer and the terms of the Employment Agreement are incorporated into this section (c) by this reference.
On May 14, 2025, the Company appointed Rudolph “Rudd” Bakker, age 59, to the Company’s board of directors.
On April 13, 2025, 374Water Inc. (the “Company”) appointed Stephen Jones to the Company’s Board of Directors, effective April 14, 2025.
On April 11, 2025, Kevin Mohan resigned as Chief Investment Officer of Sadot Group Inc. (the “Company”), effective May 5, 2025.
On April 16, 2025, Bill Wade was appointed to Goosehead Insurance, Inc.’s (the “Company”) Board of Directors (the “Board”).
On April 17, 2025, the Company announced the appointment of William J. Kelley Jr. to the position of Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective as of the CFO Effective Date.
On April 16, 2025, the Company and Ajay Kataria, the Company’s Executive Vice President, Chief Financial Officer and Principal Accounting Officer, mutually determined that, effective as of May 1, 2025, (the “CFO Effective Date”), Mr. Kataria would no longer serve in his roles as the Company’s Executive Vice President, Chief Financial Officer and Principal Accounting Officer
Effective on April 17, 2025, Gregory Mays, Chief Operating Officer of the Company, stepped down from his role as Chief Operating Officer, but will stay on as an employee of the Company for a mutually agreed timeframe, in order to assist with the transition of his duties and responsibilities.
On April 16, 2025, Dave Davis, President, Chief Financial Officer and member of the board of directors (the “Board”) of Sun Country Airlines Holdings, Inc. (the “Company”), informed the Board that he would be stepping down from his position with the Company and as a member of the Board, effective immediately.
Stephen Coley, the Company’s current Vice President, Technical Operations, will step into an interim role as Head of Operations.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.